|
|||||
|
Follow our Twitter feed of news and more! |
Jun 2, 2011 | 2:32 PM ET The tricky breast cancer cells that scientists say survive through chemotherapy treatments and sprout new cancer growths elsewhere in the body may soon meet their match. A new study shows that these cells, called breast cancer stem cells, rely on a certain molecular pathway to survive, and that [...] Published June 02, 2011 Scientists will soon begin testing a new drug for its potential to treat triple-negative breast cancer, The Telegraph reported. Researchers at the Dana-Farber Cancer Institute in Boston recently identified a pool of 15 genes associated with accelerating the growth of this aggressive disease. The discovery will now allow scientists to begin clinical trials on a [...] Thursday, June 2, 2011 PETER CAVE: Basal breast cancer is a particularly aggressive form of the disease. It’s typically found in younger women, and unlike other types of breast cancer there’s no targeted treatment for it, so about all doctors can offer sufferers is chemotherapy. But Australian researchers now say they’ve produced the most conclusive [...] 6:30AM BST 02 Jun 2011 A drug for a particularly hard to treat form of breast cancer will soon be in clinical trials after scientists isolated the genes that spur its growth. Triple-negative breast cancer is diagnosed in some 9,000 women a year in Britain – about a fifth of the total. Patients do not [...] |
  |
|||
|
home - team - contact - donate |
|||||
